Profusa Inc stock is traded at $0.3234, with a volume of 162,564. It is down -6.40% in the last 24 hours and down -63.46% over the past month. Profusa Inc is a clinical-stage digital health and medical technology company. The Company's technology enables the development of bioengineered sensors that are designed to become one with the body to detect and continuously transmit actionable, clinical-grade data for personal and medical use. The Company's first offering in the European Union, the Lumee Oxygen Platform, is designed to report reliable tissue oxygen levels at various regions of interest, both acutely and long-term. The Lumee Oxygen Platform has been designed for use in applications where monitoring of compromised tissue is beneficial, such as peripheral artery disease that results in narrowing of blood vessels and reduced blood flow to the lower limbs; chronic wounds that do not heal properly; and reconstructive surgery.
Previous Close:
$0.3455
Open:
$0.3397
24h Volume:
162,564
Relative Volume:
0.16
Market Cap:
$1.84M
Revenue:
$75,000
Net Income/Loss:
-$42.41M
P/E Ratio:
-
EPS:
-$179.82
Net Cash Flow:
-$18.47M
1W Performance:
-27.81%
1M Performance:
-63.46%
6M Performance:
-99.21%
1Y Performance:
-99.97%
1-Day Range:
$0.31$0.3488
1-Week Range:
$0.31$0.4421
52-Week Range:
$0.31$1,516.50
Profusa Inc Stock (PFSA) Company Profile
Name
Profusa IncSector
HealthcareIndustry
Medical DevicesPhone
212-494-9022Address
207 WEST 25TH ST, 9TH FLOOR, NEW YORK, USAMarket Cap
Revenue
Net Income
Cash Flow
EPS